Song, Y., Zhou, K., Jin, C., Qian, Z., Hou, M., Fan, L., Li, F., Ding, K., Zhou, H., Li, X., Chen, B., Sun, X., Song, X., Jiang, M., Zhang, Q., Liu, L., Yu, G., Hu, Y., Zhao, Z., Liu, L., Xue, H., Luo, J., He, B., Jin, X., Wang, M., Li, B., Xia, Y., & Zhu, J. (n.d.). 791 A phase II study of the anti-programmed cell death-1 (PD-1) antibody penpulimab in patients with relapsed or refractory classic hodgkin lymphoma (cHL). Journal for immunotherapy of cancer, 8, A840. http://access.bl.uk/ark:/81055/vdc_100144724881.0x000006